- Tuesday, August 14
- 10:45 AM - 12:00 PM
During this program, a specialist physician and a primary care educator will share interpretive insights into guidelines on severe asthma diagnosis, multidisciplinary patient management, and practical implications of clinical trials with available and emerging biologic medications. This program will include prerecorded video vignettes highlighting patient-clinician interactions demonstrating approaches to patient education, workups of cases of severe asthma, and ongoing monitoring of treatment responses.
Identify patients with severe asthma based on recommended measures of symptom control, medical history, and treatment responses
Describe biologic medications that have been approved by the US Food and Drug Administration for the treatment of severe asthma
Contribute to multidisciplinary care for patients for severe asthma to maximize treatment efficacy and adherence, and minimize symptoms, exacerbation risks, and medication-related toxicities
Educate patients with severe asthma about disease-related risks, long-term management goals, and treatment options
Download a PDF of the Presented SlidesDOWNLOAD
Dr. Reynold Panettieri, Jr, is the Director of the Institute for Translational Medicine and Science and Vice Chancellor for Translational Medicine and Science at Rutgers University, and the former Director of the Airways Biology Initiative at the Uni...